EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cirrhosis‐downregulated LSECtin can be retrieved by cytokines, shifts the TLR ‐induced LSECs secretome and correlates with the hepatic Th response

Sebastián Martínez-López iD, Enrique Ángel-Gomis iD, Isabel Gómez-Hurtado, Anabel Fernández-Iglesias, Javier Morante iD, Jordi Gracia-Sancho, Paula Boix, Francisco J Cubero iD, Pedro Zapater, Esther Caparrós, Rubén Francés iD

Liver International · 2024

DOI: 10.1111/liv.15836 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2024. Verfasst von Sebastián Martínez-López und 10 weiteren Autor:innen. Beteiligte Einrichtung: Hepatic and Intestinal Immunobiology Group, Departamento de Medicina Clínica, Universidad Miguel Hernández, San Juan de Alicante, Spain. Hauptthemen laut MEDLINE: Cytokines, Interleukin-10. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación, HORIZON EUROPE Framework Programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims We evaluated tolerogenic C‐type lectin LSECtin loss in cirrhosis and its potential regulation by cytokines.

Methods

Liver tissue from patients with cirrhosis and healthy controls, immortalised and generated LSECtin‐CRISPR immortalised LSECs, and murine primary LSECs from the CCl 4 model were handled.

Results

LSECtin expression was reduced in liver tissue from cirrhotic patients, and it decreased from compensated to decompensated disease. Increased phosphorylation of MAPK, Akt and NFkB was observed upon LSECtin stimulation in LSEC murine cell line, showing a pattern of inflammatory and chemotactic cytokines either restrained (IL‐10, CCL4) or unrestrained (TNF‐α, IL‐1β, IL‐6, CCL2). CD44 attenuated whereas LAG‐3 increased all substrates phosphorylation in combination with TLR4 and TLR2 ligands except for NFkB. TNF‐α, IL‐1 β, IL‐6 and CCL2 were restrained by LSECtin crosslinking on TLRs studied. Conversely, IL‐10 and CCL4 were upregulated, suggesting a LSECtin‐TLRs synergistic effect. Also, LSECtin was significantly induced after IL‐13 stimulation or combined with anti‐inflammatory cytokines in cirrhotic and immortalised LSECs. Th17 and regulatory T cells were progressively increased in the hepatic tissue from compensated to decompensated patients. A significant inverse correlation was present between gene expression levels of CLEC4G/LSECtin and RORγT and FOXP3 in liver tissues.

Conclusion

LSECtin restrains TLR proinflammatory secretome induced on LSECs by interfering immune response control, survival and MAPKs signalling pathways. The cytokine‐dependent induction of LSECtin and the association between LSECtin loss and Th17 cell subset expansion in the liver, provides a solid background for exploring LSECtin retrieval as a mechanism to reprogram LSEC homeostatic function hampered during cirrhosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CytokinesInterleukin-10HumansMiceAnimalsInterleukin-6Tumor Necrosis Factor-alphaSecretomeLiver CirrhosisNF-kappa BLectins, C-Type

Stichwörter der Autor:innen

LSECLSECtinToll‐like receptorcirrhosiscytokineshepatic T helper

Substanzen

CytokinesInterleukin-10Interleukin-6Tumor Necrosis Factor-alphaNF-kappa BLectins, C-Type

Autor:innen und Institutionen

  • Hepatic and Intestinal Immunobiology Group, Departamento de Medicina Clínica, Universidad Miguel Hernández, San Juan de Alicante, Spain.
  • IIS ISABIAL, Hospital General Universitario Dr. Balmis, Alicante, Spain.
  • CIBERehd, Instituto de Salud Carlos III, Madrid, Spain.
  • Liver Vascular Biology Research Group, IDIBAPS, Barcelona, Spain.
  • Instituto de Neurociencias, CSIC-UMH, San Juan de Alicante, Spain.
  • Department of Immunology, Ophthalmology and ENT, School of Medicine, Complutense University, Madrid, Spain.

ORCID-Profile: Sebastián Martínez-López, Enrique Ángel-Gomis, Javier Morante, Francisco J Cubero, Rubén Francés

Förderung

  • Instituto de Salud Carlos III
  • Ministerio de Ciencia e Innovación
  • HORIZON EUROPE Framework Programme
  • Conselleria de Innovación, Universidades, Ciencia y Sociedad Digital, Generalitat Valenciana
  • Comunidad de Madrid
  • Agència de Gestió d'Ajuts Universitaris i de Recerca

Zitieren

APA

Martínez-López, S., Ángel-Gomis, E., Gómez-Hurtado, I., Fernández-Iglesias, A., Morante, J., Gracia-Sancho, J., Boix, P., Cubero, F. J., Zapater, P., Caparrós, E., & Francés, R. (2024). Cirrhosis‐downregulated LSECtin can be retrieved by cytokines, shifts the TLR ‐induced LSECs secretome and correlates with the hepatic Th response. Liver International. https://doi.org/10.1111/liv.15836

Vancouver

Martínez-López S, Ángel-Gomis E, Gómez-Hurtado I, Fernández-Iglesias A, Morante J, Gracia-Sancho J, et al. Cirrhosis‐downregulated LSECtin can be retrieved by cytokines, shifts the TLR ‐induced LSECs secretome and correlates with the hepatic Th response. Liver International. 2024. doi:10.1111/liv.15836

BibTeX
@article{MartnezLpez2024,
  author = {Martínez-López, Sebastián and Ángel-Gomis, Enrique and Gómez-Hurtado, Isabel and Fernández-Iglesias, Anabel and Morante, Javier and Gracia-Sancho, Jordi and Boix, Paula and Cubero, Francisco J and Zapater, Pedro and Caparrós, Esther and Francés, Rubén},
  title = {Cirrhosis‐downregulated LSECtin can be retrieved by cytokines, shifts the TLR ‐induced LSECs secretome and correlates with the hepatic Th response},
  journal = {Liver International},
  year = {2024},
  doi = {10.1111/liv.15836}
}
Kostenlos starten →